Chemed PE Ratio 2010-2024 | CHE

Current and historical p/e ratio for Chemed (CHE) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Chemed PE ratio as of July 22, 2024 is 25.44.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Chemed PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-07-22 542.16 29.18
2024-03-31 641.93 $18.58 34.55
2023-12-31 584.36 $17.92 32.61
2023-09-30 519.00 $16.15 32.14
2023-06-30 540.52 $15.00 36.03
2023-03-31 536.23 $15.89 33.75
2022-12-31 508.62 $17.12 29.71
2022-09-30 434.68 $17.54 24.78
2022-06-30 467.01 $17.27 27.04
2021-12-31 525.58 $16.88 31.14
2021-09-30 461.75 $19.03 24.26
2021-06-30 470.69 $18.70 25.17
2021-03-31 455.81 $19.33 23.58
2020-12-31 527.57 $20.33 25.95
2022-03-31 503.62 $16.75 30.07
2020-09-30 475.47 $16.49 28.83
2020-06-30 446.19 $15.91 28.04
2020-03-31 428.22 $13.98 30.63
2019-12-31 433.88 $13.30 32.62
2019-09-30 412.13 $12.60 32.71
2019-06-30 355.88 $12.10 29.41
2019-03-31 315.38 $12.29 25.66
2018-12-31 278.87 $12.25 22.77
2018-09-30 314.32 $12.24 25.68
2018-06-30 316.21 $11.31 27.96
2018-03-31 267.89 $6.69 40.04
2017-12-31 238.33 $5.81 41.02
2017-09-30 197.92 $4.50 43.98
2017-06-30 200.05 $3.99 50.14
2017-03-31 178.46 $6.82 26.17
2016-12-31 156.47 $6.49 24.11
2016-09-30 137.35 $6.27 21.91
2016-06-30 132.47 $6.30 21.03
2016-03-31 131.39 $6.37 20.63
2015-12-31 145.05 $6.63 21.88
2015-09-30 129.02 $6.30 20.48
2015-06-30 126.53 $6.01 21.05
2014-12-31 101.61 $5.58 18.21
2014-09-30 98.75 $5.15 19.17
2014-06-30 89.74 $5.16 17.39
2014-03-31 85.46 $4.74 18.03
2013-12-31 73.03 $4.39 16.64
2015-03-31 115.03 $4.28 26.88
2013-09-30 67.97 $4.28 15.88
2013-06-30 68.67 $4.41 15.57
2013-03-31 75.62 $4.74 15.95
2012-12-31 64.70 $4.63 13.97
2012-09-30 65.18 $4.54 14.36
2012-06-30 56.69 $4.51 12.57
2012-03-31 58.62 $4.35 13.48
2011-12-31 47.77 $4.13 11.57
2011-09-30 51.13 $3.80 13.46
2011-06-30 60.78 $3.67 16.56
2011-03-31 61.66 $3.55 17.37
2010-12-31 58.66 $3.55 16.52
2010-09-30 52.50 $3.35 15.67
2010-06-30 50.22 $3.28 15.31
2010-03-31 49.87 $3.22 15.49
2009-12-31 43.90 $3.23 13.59
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.208B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00